Stephen Gardner, the former CEO of Amtrak, has been appointed to the strategic advisory board of financial consultancy Telos Advisors. The move brings one of the rail industry's most prominent figures to a firm specializing in complex infrastructure projects.
Wolfe Research upgrades Broadcom to 'Outperform,' citing its pivotal role in Google's expanding TPU program and broader AI infrastructure demand, setting a $400 price target despite recent market volatility.
Italian authorities announced the disruption of a series of cyberattacks, attributed to Russian actors, aimed at Olympic infrastructure and diplomatic sites just hours before the Games commence, amid heightened security and political tensions.
A routine student achievement report in California's Pajaro Valley Unified School District ignited a tense exchange over language, as a board vice president demanded the term "homeless" be replaced with "unhoused," calling the former personally offensive.
A temporary spending bill has averted a full government shutdown, but funding for the Department of Homeland Security remains in limbo. With a one-week deadline, lawmakers are locked in a contentious debate over reforming ICE and Border Patrol tactics, while a new study underscores immigrants' fiscal contributions to the U.S. economy.
Federal immigration authorities will significantly reduce their operational footprint in Minneapolis, citing enhanced cooperation with local jails and officials that allows for a more targeted approach.
Michael Hartnett, Bank of America's chief investment strategist, issues a stark warning on global stocks as markets show extreme overbought conditions. The caution follows a sharp selloff in software shares and rising volatility, prompting a defensive shift towards gold, bonds, and commodities.
Industrial components maker Kadant Inc. (KAI) has finalized a €157 million deal to acquire Austrian precision parts manufacturer voestalpine BÖHLER Profil, a key supplier for over three decades. While the acquisition strengthens Kadant's consumables-focused strategy and secures critical patented technology, executives caution that accounting complexities and existing inventory will dilute earnings through much of 2026 before margin benefits materialize.
The sharp retreat in cocoa futures from record highs presents a new strategic dilemma for Mondelez and its rivals, forcing a delicate balance between protecting margins and retaining cost-sensitive consumers in a volatile market.
AMD's stock fell sharply post-earnings despite beating Q4 estimates, as its Q1 guidance failed to meet lofty market expectations. The sell-off highlights the punishing standards for AI-focused tech giants and raises questions about stretched valuations across the sector.
Analysts at DA Davidson have increased their price target for Sierra Bancorp (BSRR) to $44, maintaining a Buy rating after the bank reported a solid quarter fueled by better-than-expected credit costs and an improved growth trajectory.
The high-flying coffee chain's stock continues its recent decline as investors weigh its premium valuation against a potential slowdown in consumer discretionary spending.
Analysts at Northland Capital have downgraded Graham Corporation (NYSE: GHM), citing a stock price nearing full valuation and management's guidance for a significant slowdown in orders by 2026. The move comes just after Graham's strategic $35 million acquisition of mixing technology pioneer FlackTek.
Once a Wall Street darling, The Trade Desk (TTD) has seen its shares collapse by over two-thirds. As the adtech pioneer battles fierce competition and internal turmoil, investors are left weighing its deep value against its uncertain future.
McDonald's USA has unveiled a series of executive moves, naming Loek Beckers as its new Chief Financial Officer and promoting Luis Quintiliano to U.S. National Field President, as veteran Myra Doria prepares for retirement.
Goldman Sachs' latest Conviction List highlights five dividend-paying stocks with significant projected gains, offering investors a blend of income and growth in a volatile market.
Biopharmaceutical firm Ardelyx has been granted a crucial U.S. patent covering the oral formulation of its drug tenapanor, solidifying protection for its commercial products Ibsrela and Xphozah until late 2042 and bolstering its competitive position in the chronic kidney disease treatment landscape.
Polaryx Therapeutics is set to present new late-breaking data for its investigational therapy PLX-200 at the 2026 WORLDSymposium, bolstering confidence in the upcoming launch of its Phase 2 Soteria trial targeting multiple rare neurodegenerative disorders.
A new 10,000-meter drilling program aims to confirm the western extension of the Rose West lithium discovery in Quebec, a critical step toward defining an initial resource that could bolster the broader Rose Project's economic potential.
The technology and marketing firm SharpLink Gaming has formally rebranded as Sharplink, Inc., a move signaling a strategic pivot beyond its gaming industry roots. The change, effective February 3, follows a filing in Delaware.
